Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Opening SoonPAR-26-132

Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not

National Institutes of Health opportunity PAR-26-132

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-26-132Grants.gov
Related Grants
HealthUpcoming
Understanding Cerebellar Contributions to Cognitive and Affective Functions in Aging and Alzheimer's Disease/Alzheimer's Disease-Related Dementias
Varies
HealthUpcoming
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
Varies
Health● Open
DoW Parkinson’s, Early Investigator Research Award
Varies
06 Nov 2026(35d)
Health● Open
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Varies
17 Nov 2026(46d)
Funding Amount
Varies
USD
Apply Now
Programme Details
Programme Code
PAR-26-132